Owen N. Witte - 11 Aug 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
Veer Bhavnagri as attorney-in-fact
Issuer symbol
ALLO
Transactions as of
11 Aug 2022
Transactions value $
-$251,250
Form type
4
Date filed
15 Aug 2022, 17:40
Previous filing
23 Jun 2022
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Sale -$165K -10K -4.29% $16.50 223K 11 Aug 2022 Direct
transaction ALLO Common Stock Sale -$86.3K -5K -2.24% $17.25* 218K 12 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.